Showing results (271-280 of 287) with videos related to
Sort By:
Pageof 29
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 16, 2024
Acute Severe Ulcerative Colitis: An International Delphi Consensus on Clinical Trial Design and EndpointsSailish Honap, Vipul Jairath, Bruce E Sands, et al.Gastroenterology|April 12, 2022
Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal SurgeryBenjamin L Cohen, Phillip Fleshner, Sunanda V Kane, et al.Lancet (London, England)|June 1, 2022
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trialsSilvio Danese, Séverine Vermeire, Wen Zhou, et al.The American Journal of Gastroenterology|January 14, 2022
Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel DiseasesMichael D Kappelman, Kimberly N Weaver, Xian Zhang, et al.Alimentary Pharmacology & Therapeutics|November 10, 2015
Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammationA J F Coimbra, J Rimola, S O'Byrne, et al.Journal of Pediatric Gastroenterology and Nutrition|February 15, 2024
Humoral immune response and safety of SARS-CoV-2 vaccination in very early onset inflammatory bowel diseaseArthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.The American Journal of Gastroenterology|January 26, 2024
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter ExperienceJeffrey A Berinstein, Taylor Karl, Anish Patel, et al.The American Journal of Gastroenterology|November 4, 2010
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?Geert R D'Haens, Remo Panaccione, Peter D R Higgins, et al.Gastroenterology|July 3, 2018
Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative ColitisHans Herfarth, Edward L Barnes, John F Valentine, et al.Development (Cambridge, England)|October 24, 2022
Mapping the adult human esophagus in vivo and in vitroDaysha Ferrer-Torres, Joshua H Wu, Charles J Zhang, et al.Pageof 29